Clinical Trial Update: Study of JANX011 in Healthy Adult Volunteers to Assess Safety and Tolerability. [EARLY_Phase 1]

View source ↗

Summary

Janux Therapeutics is conducting a Phase 1 study of JANX011 in healthy adult volunteers to assess safety and tolerability; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Diseases

Drugs mentioned

• JANX011

Snippet

Sponsor: Janux Therapeutics | Conditions: Autoimmune | EARLY_Phase 1 | Status: RECRUITING